Advertisement
The Covaris business was built upon the proprietary and patented AFA(TM)(Adaptive Focused Acoustics) technology. The AFA technology has the abilityof impart both thermal and non-contact control of application processes,which, in many cases, could not be obtained prior to the development of AFAtechnology. This unique and sustainable competitive advantage enables Covaristo develop a broad range of applications in Genomics, Proteomics and DrugDiscovery research.
Advertisement
"There has been an increased systematic acceptance of our technology overthe past few years. We are pleased to see our sample preparation toolsgaining market acceptance and incorporated into daily research investigationsthroughout research institutions and pharmaceutical companies, such as theBroad Institute, GlaxoSmithKline and Merck," said Jim Laugharn, President andCEO of Covaris, "with the help of our customers, we have developed andoptimized solutions for various key applications, such as DNA shearing fornext-gen sequencing, RNA extraction for gene expression profiling, analyte andsmall molecule extraction from difficult tissue samples, compound formulation,and ADME/Tox."
"I'm truly impressed with the solid technology and product platformCovaris has developed and its experienced team of people with well-balancedknowledge ranging from acoustic physics, mechanical engineering to biophysicsand molecular biology," commented Jennifer Wu, the newly hired Director ofMarketing, "I'm honored and excited to join Covaris to further expeditemarketing programs, market development and customer experience enhancement."
About Covaris, Inc.
Covaris, Inc. is a rapidly growing life science instrument company. Itsproprietary instrument platform, based on patented Adaptive Focused Acoustic(AFA) technology brings unsurpassed speed and efficiency to biological andchemical sample preparation. The AFA process, based on shock wave physics,delivers controlled, precise, and accurate energy to biological and chemicalsamples. The process is non-contact, isothermal, and rapid. Leadingpharmaceutical and biotechnology companies worldwide are using Covarisinstruments for RNA extraction, Compound Dissolution, Drug Metabolism tissueextraction, and much more. Information about Covaris is available athttp://www.covarisinc.com.
SOURCE Covaris Incorporated
